Cardiometabolic Archives - Page 3 of 6

Veiled Threats: New Findings Show More Links Between EDCs and Cardiovascular Health

As heart disease continues to kill more people than any other ailment annually, more endocrine research is linking endocrine disruptors to cardiovascular health. Patients can reduce their own exposure to these compounds. Cardiovascular disease (CVD) is the leading cause of mortality in the U.S., responsible for a quarter of all deaths, with someone succumbing to...

Heart Attack, Stroke Risk Declines among People with Diabetes

Two-decade study shows overall mortality risk remains higher than general population The rate of heart attacks, strokes and other cardiovascular complications has improved among people with diabetes over the past 20 years, narrowing the gap in cardiovascular mortality rates between individuals with and without diabetes, according to a new study published in The Journal of Clinical...

People with Brown Fat May Burn 15 Percent More Calories

New data highlights how cold exposure activates brown fat, energy metabolism Short-term cold exposure may help people with brown fat burn 15 percent more calories than those without, according to a small study published in The Journal of Clinical Endocrinology & Metabolism. Unlike white fat, brown fat burns calories through fatty acid oxidation and heat production and is considered a promising target in the fight against the obesity epidemic. The biggest activator of brown fat is moderate cold exposure. “This data improves our understanding of how brown fat works...

Statins and Diabetes: How Big Is the Risk?

Studies linking statins to diabetes receive media attention but should not distract clinicians from the goal of reducing cardiovascular risk. Almost eight years after the Food and Drug Administration (FDA) added a warning to statin labels about the drugs increasing fasting blood sugar and hemoglobin A1C levels — and by inference raising the risk of...

Q&A: James L. Rosenzweig, MD

Endocrine News talks with James Rosenzweig, MD, chair of the task force that developed the latest Endocrine Society Clinical Practice Guideline on Preventing Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk. A new Endocrine Society clinical practice guideline states that measuring waistline, blood pressure, cholesterol, and blood sugar during doctor’s visits could...

CEU Preview: Challenging Cases in Lipid Management with Lisa Tannock, MD

Next month, the Endocrine Society’s Clinical Endocrinology Update will kick off in Miami, during which attendees will hear about the latest breakthroughs in patient care, as well as those cases that may prove difficult for clinicians. One such session is Lisa Tannock’s Meet-the-Professor presentation on Thursday, September 5, titled “Challenging Cases in Lipid Management.” Cardiovascular...

Review Looks at Genetic Components in Development of Hypertension

A paper recently published in Endocrine Reviews concludes that primary hypertension is not a disease but rather a syndrome, and that genetics may hold the key to targeted and individualized treatment. The review, by Worapaka Manosroi, MD, and Gordon H. Williams, MD, of Brigham and Women’s Hospital and Harvard Medical School in Boston, points out...

Midlife Women Transitioning to Menopause Have a Higher Risk of Metabolic Syndrome, Which Predisposes to Heart Disease and Type 2 Diabetes

Multi-ethnic study shows midlife women with more physical activity or a lower calorie diet have less risk of developing the disease Midlife women transitioning to menopause may be able to lower their risk of developing heart disease and type 2 diabetes, if they exercise more or eat a lower calorie diet, according to a new...

Cardiometabolic

Endocrine news on twitter